ACOX2

UniProt ID: Q99424
Organism: Homo sapiens
Review Status: INITIALIZED
📝 Provide Detailed Feedback

Gene Description

ACOX2 is the human peroxisomal branched-chain acyl-CoA oxidase (EC 1.3.3.6), a FAD-dependent flavoenzyme of the acyl-CoA oxidase family. It catalyzes the first, oxygen-dependent and rate-limiting dehydrogenation step of peroxisomal beta-oxidation, removing two hydrogens and introducing a trans-2,3 double bond into the acyl-CoA substrate while generating hydrogen peroxide as a byproduct. Its principal physiological substrates are the C27 bile-acid intermediates (25S)-3alpha,7alpha,12alpha-trihydroxy- cholestanoyl-CoA (THCA-CoA) and dihydroxycholestanoyl-CoA (DHCA-CoA); ACOX2 initiates the side-chain shortening that converts these C27 cholestanoic acids into the mature C24 bile acids (cholic and chenodeoxycholic acid). It also oxidizes 2-methyl-branched-chain fatty acyl-CoA esters such as (2S)-pristanoyl-CoA (with redundancy to ACOX3) and monomethyl branched-chain fatty acids, acting stereospecifically on (2S)-methyl isomers, and can oxidize straight-chain acyl-CoAs with low efficiency. ACOX2 is a homodimer that resides in the peroxisomal matrix, imported via its C-terminal SKL (PTS1) targeting signal. It is expressed in many tissues, most abundantly in liver, kidney and heart. Loss-of-function causes ACOX2 deficiency (congenital bile acid synthesis defect 6, CBAS6), an autosomal recessive disorder marked by accumulation of toxic C27 bile-acid intermediates, persistent hypertransaminasemia and liver fibrosis, with variable neurological features.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005504 fatty acid binding
IBA
GO_REF:0000033
MARK AS OVER ANNOTATED
Summary: Fatty acid binding propagated by phylogenetic inference. Substrate binding is implicit in the acyl-CoA oxidase catalytic mechanism, but a bare "fatty acid binding" molecular function term is uninformative for this enzyme, whose informative MF is its acyl-CoA oxidase (dehydrogenase) activity. Retained but flagged as an over-annotation.
Reason: ACOX2 acts on acyl-CoA thioesters (branched-chain and C27 bile-acid CoA esters), not on free fatty acids, and its informative molecular function is captured by the acyl-CoA oxidase activity terms. A generic "fatty acid binding" adds little functional information and is more precisely represented by the catalytic MF terms.
Propagation Review
Root cause: TERM SCOPING PROBLEM
Failure modes: GRANULARITY MISMATCH ROLE CONFLATION
Sources checked:
PANTHER:PTN000097533 SUPPORTS SOURCE BUT NOT TARGET
Family-level "fatty acid binding" propagated from the acyl-CoA oxidase clade; ACOX2 acts on acyl-CoA thioesters, and the informative MF is its acyl-CoA oxidase activity.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Involved in peroxisomal beta-oxidation of branched-chain fatty acids (BCFAs) and bile acids intermediates.
GO:0033540 fatty acid beta-oxidation using acyl-CoA oxidase
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetically inferred involvement in fatty acid beta-oxidation via an acyl-CoA oxidase. This is exactly the pathway ACOX2 participates in, catalyzing the first oxidase step of peroxisomal beta-oxidation of branched-chain and bile-acid CoA esters.
Reason: Directly supported by experimental data (IDA/IMP from PMID:27884763) and by the UniProt PATHWAY assignment to peroxisomal fatty acid beta-oxidation. The IBA is at an appropriate level of specificity for an acyl-CoA-oxidase family enzyme.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Lipid metabolism; peroxisomal fatty acid beta-oxidation.
GO:0120524 long-chain fatty acyl-CoA oxidase activity
IBA
GO_REF:0000033
MARK AS OVER ANNOTATED
Summary: Long-chain acyl-CoA oxidase activity inferred phylogenetically. ACOX2 can oxidize straight-chain long-chain acyl-CoAs (e.g. hexadecanoyl-CoA/C16-CoA) but only with low efficiency; its physiological substrates are branched-chain and C27 bile-acid CoA esters. Retained but noted as a minor/low-efficiency activity rather than a core function.
Reason: UniProt explicitly states ACOX2 oxidizes straight-chain acyl-CoAs (C10-CoA, C16-CoA) only with low efficiency; long-chain straight-chain oxidation is the physiological role of ACOX1, not ACOX2. The term is not wrong (there is measurable C16-CoA activity) but over-states its importance relative to the branched-chain/bile-acid core function.
Propagation Review
Root cause: TERM SCOPING PROBLEM
Failure modes: FUNCTIONAL DIVERGENCE GRANULARITY MISMATCH
Sources checked:
UniProtKB:Q15067 SUPPORTS SOURCE BUT NOT TARGET
Long-chain acyl-CoA oxidase activity fits ACOX1-type members; ACOX2 oxidizes straight long-chain acyl-CoAs only with low efficiency, its physiological substrates being branched-chain and C27 bile-acid CoA esters.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
acyl CoAs such as C10-CoA and C16-CoA with low efficiency
GO:0005777 peroxisome
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetically inferred peroxisomal localization/activity. ACOX2 carries a C-terminal SKL (PTS1) signal and is directly demonstrated to be peroxisomal in human liver, and is active within the peroxisome.
Reason: Consistent with strong experimental evidence (IDA in PMID:8943006 and PMID:2079609; IMP in PMID:27884763) and the UniProt SUBCELLULAR LOCATION. is_active_in is appropriate for a matrix enzyme acting inside the peroxisome.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
SUBCELLULAR LOCATION: Peroxisome
GO:0050660 flavin adenine dinucleotide binding
IBA
GO_REF:0000033
ACCEPT
Summary: FAD binding inferred phylogenetically. ACOX2 is a FAD-dependent flavoprotein oxidase; FAD is an essential cofactor for the oxidative dehydrogenation reaction.
Reason: Supported by the UniProt COFACTOR annotation (FAD) and by the flavoprotein character of the whole acyl-CoA oxidase family. Reactome also describes the ACOX2:FAD holoenzyme.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Name=FAD; Xref=ChEBI:CHEBI:57692
GO:0000038 very long-chain fatty acid metabolic process
IBA
GO_REF:0000033
MARK AS OVER ANNOTATED
Summary: Involvement in very long-chain fatty acid metabolism inferred phylogenetically. ACOX2's physiological substrates are 2-methyl-branched-chain acyl-CoAs and C27 bile-acid intermediates, not straight very-long-chain fatty acids, which are the substrates of ACOX1. This appears to be over-propagation across the acyl-CoA oxidase clade.
Reason: Straight VLCFA beta-oxidation is the role of ACOX1 (palmitoyl-CoA oxidase). Human liver enzymology (PMID:2079609) distinguishes the separate trihydroxycoprostanoyl-CoA oxidase (ACOX2) from the palmitoyl-CoA oxidase, and UniProt notes only low-efficiency straight-chain activity for ACOX2. The VLCFA-metabolism assignment likely reflects family-level IBA transfer rather than ACOX2's actual physiological substrate range.
Propagation Review
Root cause: PROPAGATION BAD
Failure modes: FUNCTIONAL DIVERGENCE
Sources checked:
UniProtKB:Q15067 SUPPORTS SOURCE BUT NOT TARGET
Very-long-chain fatty acid metabolism is the role of ACOX1-type members; human liver enzymology (PMID:2079609) separates the trihydroxycoprostanoyl-CoA oxidase (ACOX2) from the palmitoyl-CoA oxidase, so this process should not transfer to ACOX2.
Supporting Evidence:
PMID:2079609
The results show that human liver, as rat liver, contains a separate trihydroxycoprostanoyl-CoA oxidase.
GO:0033791 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity
IBA
GO_REF:0000033
ACCEPT
Summary: THCA-CoA oxidase (24-hydroxylase) activity inferred phylogenetically, with ACOX2 itself among the supporting genes (UniProtKB:Q99424 in the WITH/FROM). This is the bile-acid-specific reaction ACOX2 catalyzes on the C27 intermediate THCA-CoA.
Reason: Directly supported by experimental evidence (IDA in PMID:27884763) and by the UniProt catalytic activity for (25S)-THCA-CoA oxidation (Rhea:46728). This is a core molecular function.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Reaction=(25S)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oyl-
GO:0003997 acyl-CoA oxidase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Acyl-CoA oxidase activity (EC 1.3.3.6) assigned electronically from InterPro/Rhea. This is the defining molecular function of ACOX2 and is experimentally confirmed.
Reason: This parent MF term precisely captures ACOX2's biochemistry (a 2,3-saturated acyl-CoA + O2 -> a (2E)-enoyl-CoA + H2O2, EC 1.3.3.6), confirmed experimentally in PMID:27884763 and via the UniProt catalytic activity (Rhea:38959). It is the best single molecular function term for this enzyme.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Reaction=a 2,3-saturated acyl-CoA + O2 = a (2E)-enoyl-CoA + H2O2;
GO:0005777 peroxisome
IEA
GO_REF:0000120
ACCEPT
Summary: Peroxisomal localization assigned electronically (InterPro / UniProt SubCell). Confirmed by direct experimental evidence.
Reason: Consistent with the UniProt SUBCELLULAR LOCATION (Peroxisome) and multiple experimental annotations (IDA/IMP). The SKL C-terminal PTS1 targets the protein to the peroxisome.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
SUBCELLULAR LOCATION: Peroxisome
GO:0005782 peroxisomal matrix
IEA
GO_REF:0000117
ACCEPT
Summary: Peroxisomal matrix localization assigned by ARBA machine-learning model. As a soluble PTS1-targeted matrix enzyme, ACOX2 resides in the peroxisomal matrix, consistent with Reactome placing its reactions in the peroxisomal matrix.
Reason: ACOX2 is a soluble matrix flavoenzyme (SKL/PTS1 import, not membrane-bound). This is a more specific and accurate compartment than the parent "peroxisome" term, and matches the Reactome curated location of its catalytic reactions.
Supporting Evidence:
Reactome:R-HSA-192335
This dehydrogenation reaction occurs in the peroxisomal matrix.
GO:0006631 fatty acid metabolic process
IEA
GO_REF:0000002
ACCEPT
Summary: Broad fatty acid metabolic process assigned from InterPro. Correct but general; ACOX2's specific role is captured by fatty acid beta-oxidation and bile acid biosynthetic process terms.
Reason: A true but broad parent process term. ACOX2 participates in fatty acid metabolism (peroxisomal beta-oxidation of branched-chain fatty acids). Kept as an accurate high-level annotation; more specific BP terms are also present.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Involved in peroxisomal beta-oxidation of branched-chain fatty acids (BCFAs) and bile acids intermediates.
GO:0006635 fatty acid beta-oxidation
IEA
GO_REF:0000002
ACCEPT
Summary: Fatty acid beta-oxidation assigned electronically from InterPro. ACOX2 catalyzes the first oxidase step of peroxisomal beta-oxidation, so this is an accurate parent of the more specific "fatty acid beta-oxidation using acyl-CoA oxidase" term.
Reason: Directly supported by the UniProt PATHWAY (peroxisomal fatty acid beta-oxidation) and by experimental data. This is a core biological process for ACOX2.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Lipid metabolism; peroxisomal fatty acid beta-oxidation.
GO:0016402 pristanoyl-CoA oxidase activity
IEA
GO_REF:0000116
ACCEPT
Summary: Pristanoyl-CoA oxidase activity assigned from Rhea (RHEA:40459). ACOX2 oxidizes (2S)-pristanoyl-CoA, a 2-methyl-branched-chain fatty acyl-CoA, though it acts redundantly with ACOX3 for this substrate.
Reason: Supported by the UniProt catalytic activity for (2S)-pristanoyl-CoA (Rhea:40459, ECO:0000269|PubMed:29287774). This is a genuine branched-chain fatty acyl-CoA oxidase activity of ACOX2.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Reaction=(2S)-pristanoyl-CoA + O2 = (2E)-pristenoyl-CoA + H2O2;
GO:0016491 oxidoreductase activity
IEA
GO_REF:0000117
MARK AS OVER ANNOTATED
Summary: Root-level oxidoreductase activity from ARBA. Correct but very general; ACOX2's oxidoreductase function is precisely captured by acyl-CoA oxidase activity.
Reason: This is a high-level grouping term that is technically true (ACOX2 is an oxidoreductase) but uninformative given the specific acyl-CoA oxidase activity (EC 1.3.3.6) is already annotated. Retained but flagged as too general.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
EC=1.3.3.6
GO:0016627 oxidoreductase activity, acting on the CH-CH group of donors
IEA
GO_REF:0000002
ACCEPT
Summary: Oxidoreductase acting on the CH-CH group of donors, from InterPro. This is the correct mechanistic class (introduction of a C2-C3 double bond), an intermediate parent of acyl-CoA oxidase activity.
Reason: Accurate mechanistic parent term: ACOX2 desaturates the alpha-beta (CH-CH) bond of the acyl-CoA. It is subsumed by the more specific acyl-CoA oxidase activity but is not incorrect. Kept as an accurate intermediate-level annotation.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
introduces a trans double bond between the alpha and beta carbons of the acyl CoA molecules
GO:0033540 fatty acid beta-oxidation using acyl-CoA oxidase
IEA
GO_REF:0000117
ACCEPT
Summary: Fatty acid beta-oxidation using acyl-CoA oxidase, assigned by ARBA. This is the precise pathway term for ACOX2 and is also supported experimentally.
Reason: Duplicate of the experimentally supported (IDA/IMP, PMID:27884763) and IBA annotations for the same term. Precisely describes ACOX2's contribution to peroxisomal beta-oxidation.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Lipid metabolism; peroxisomal fatty acid beta-oxidation.
GO:0050660 flavin adenine dinucleotide binding
IEA
GO_REF:0000002
ACCEPT
Summary: FAD binding assigned from InterPro. Duplicate of the IBA/ISS FAD-binding annotations; ACOX2 is a FAD-dependent flavoprotein.
Reason: Supported by the UniProt COFACTOR (FAD) annotation. FAD is the essential redox cofactor of this oxidase.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Name=FAD; Xref=ChEBI:CHEBI:57692
GO:0071949 FAD binding
IEA
GO_REF:0000002
ACCEPT
Summary: FAD binding (GO:0071949) assigned from InterPro. Semantically equivalent to the GO:0050660 FAD-binding annotations; both describe binding of the FAD cofactor.
Reason: Supported by the UniProt COFACTOR (FAD) annotation. Retained; this is a valid (if redundant with GO:0050660) representation of FAD cofactor binding.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Name=FAD; Xref=ChEBI:CHEBI:57692
GO:0120523 medium-chain fatty acyl-CoA oxidase activity
IEA
GO_REF:0000116
MARK AS OVER ANNOTATED
Summary: Medium-chain acyl-CoA oxidase activity from Rhea (RHEA:40179, decanoyl-CoA). ACOX2 can oxidize the medium-chain substrate decanoyl-CoA (C10-CoA), but UniProt characterizes straight-chain oxidation as low efficiency.
Reason: There is measurable in vitro activity on decanoyl-CoA (Rhea:40179, PubMed:29287774), so the term is not wrong, but UniProt explicitly notes straight-chain acyl-CoA oxidation (C10-CoA, C16-CoA) is low efficiency. This is a minor activity, not a core physiological function, which is branched-chain and bile-acid CoA-ester oxidation.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
acyl CoAs such as C10-CoA and C16-CoA with low efficiency
GO:0120524 long-chain fatty acyl-CoA oxidase activity
IEA
GO_REF:0000116
MARK AS OVER ANNOTATED
Summary: Long-chain acyl-CoA oxidase activity from Rhea (RHEA:40167, hexadecanoyl-CoA). Duplicate of the IBA long-chain annotation; represents low-efficiency straight-chain activity.
Reason: In vitro C16-CoA (hexadecanoyl-CoA) oxidation exists (Rhea:40167), but UniProt states it is low efficiency; straight-chain long-chain oxidation is the physiological role of ACOX1. Flagged as over-annotation relative to ACOX2's branched-chain/bile-acid core.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
acyl CoAs such as C10-CoA and C16-CoA with low efficiency
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
MARK AS OVER ANNOTATED
Summary: Bare "protein binding" from a high-throughput affinity-capture interactome screen (BioPlex; ACOX2 with STRN3, UniProtKB:Q13033). Uninformative molecular function.
Reason: Per curation guidelines, bare "protein binding" (GO:0005515) is uninformative. This interaction derives from a genome-scale interactome mapping study, not a functional characterization; there is no evidence it reflects a physiologically meaningful complex of ACOX2. Retained (not removed, per policy for experimental IPIs) but marked as over-annotated.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Q99424; Q13033: STRN3
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
MARK AS OVER ANNOTATED
Summary: Bare "protein binding" from the HuRI binary interactome map (ACOX2 with DYNLT1, UniProtKB:P63172). Uninformative molecular function.
Reason: Bare "protein binding" from a systematic binary (Y2H) interactome screen is uninformative and does not point to a specific biochemical function of ACOX2. Retained per policy for experimental IPIs but flagged as over-annotated.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Q99424; P63172: DYNLT1
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
MARK AS OVER ANNOTATED
Summary: Bare "protein binding" from a proteome-scale interactome network study (BioPlex 3.0; ACOX2 with STRN3, UniProtKB:Q13033). Uninformative molecular function.
Reason: Bare "protein binding" from a high-throughput interactome dataset is uninformative for curation and does not establish a functionally relevant ACOX2 complex. Retained per policy for experimental IPIs but flagged as over-annotated.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Q99424; Q13033: STRN3
GO:0006699 bile acid biosynthetic process
IDA
PMID:27884763
ACOX2 deficiency: An inborn error of bile acid synthesis ide...
ACCEPT
Summary: Direct experimental evidence that ACOX2 is involved in bile acid biosynthesis: patients with the R225W mutation accumulate C27 intermediates and lack C24 bile acids, and overexpression of wild-type (but not mutant) ACOX2 enhances biotransformation of THCA into cholic acid. This is a core biological process.
Reason: Strong IDA evidence from PMID:27884763 places ACOX2 in the peroxisomal side-chain shortening of C27 cholestanoic acids to C24 bile acids. This is one of ACOX2's two core physiological roles.
Supporting Evidence:
PMID:27884763
Acyl-CoA oxidase (ACOX2) is involved in the shortening of C27 cholesterol derivatives to generate C24 bile acids.
PMID:27884763
THCA biotransformation into cholic acid was enhanced in cells overexpressing ACOX2, but not in those overexpressing mutACOX2.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9033235
MARK AS OVER ANNOTATED
Summary: Cytosol localization from a Reactome peroxisomal-import reaction (PEX5 cargo translocating from cytosol to the peroxisomal matrix). This reflects the transient cytosolic import intermediate of matrix proteins, not the compartment where ACOX2 is catalytically active.
Reason: ACOX2 is a PTS1 (SKL) matrix enzyme; peroxisomal matrix proteins are synthesized in the cytosol and imported post-translationally, so a transient cytosolic pool exists, but the functional/steady-state location is the peroxisomal matrix. The cytosol annotation captures the import-pathway transit state rather than the site of ACOX2 activity.
Supporting Evidence:
Reactome:R-HSA-9033235
Cargo of PEX5S,L translocates from the cytosol to the peroxisomal matrix
GO:0005829 cytosol
TAS
Reactome:R-HSA-9033236
MARK AS OVER ANNOTATED
Summary: Cytosol localization from a Reactome peroxisomal-import docking reaction (PEX5:cargo binding the PEX13/PEX14 docking-translocation module). Like the sibling annotation, this reflects the cytosolic import intermediate, not ACOX2's catalytic compartment.
Reason: Same rationale as the other cytosol annotation: this is the transient cytosolic import/docking state of the PTS1-targeted matrix enzyme, not its functional location, which is the peroxisomal matrix.
Supporting Evidence:
Reactome:R-HSA-9033236
PEX5S,L:Cargo binds PEX13:PEX14:PEX2:PEX10:PEX12 (Docking and Translocation
GO:0005777 peroxisome
IMP
PMID:27884763
ACOX2 deficiency: An inborn error of bile acid synthesis ide...
ACCEPT
Summary: Peroxisomal localization confirmed by immunofluorescence in HepG2 cells overexpressing wild-type and R225W-mutant ACOX2; both showed peroxisomal localization. Direct experimental support for the peroxisome location.
Reason: PMID:27884763 experimentally demonstrates peroxisomal localization of ACOX2 (both WT and mutant). Consistent with the UniProt SUBCELLULAR LOCATION and the IDA localizations.
Supporting Evidence:
PMID:27884763
Immunofluorescence studies showed similar protein size and peroxisomal localization for both normal and mutated variants.
GO:0033540 fatty acid beta-oxidation using acyl-CoA oxidase
IDA
PMID:27884763
ACOX2 deficiency: An inborn error of bile acid synthesis ide...
ACCEPT
Summary: Direct experimental evidence for ACOX2's role in acyl-CoA-oxidase-mediated beta-oxidation, shown via its bile-acid intermediate (THCA) processing that requires functional ACOX2. Core biological process.
Reason: PMID:27884763 demonstrates that functional ACOX2 is required for the oxidase step that processes C27 bile-acid CoA intermediates during peroxisomal beta-oxidation. Precise pathway term.
Supporting Evidence:
PMID:27884763
THCA biotransformation into cholic acid was enhanced in cells overexpressing ACOX2, but not in those overexpressing mutACOX2.
GO:0033791 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity
IDA
PMID:27884763
ACOX2 deficiency: An inborn error of bile acid synthesis ide...
ACCEPT
Summary: Direct experimental evidence for THCA-CoA oxidase activity: wild-type ACOX2, but not the R225W mutant, enhances biotransformation of THCA to cholic acid, establishing this specific catalytic activity on the C27 bile-acid intermediate. Core molecular function.
Reason: IDA evidence in PMID:27884763 directly supports ACOX2's activity on the C27 trihydroxycholestanoyl-CoA substrate. Corresponds to the UniProt catalytic activity (Rhea:46728) for (25S)-THCA-CoA oxidation. This is a core molecular function.
Supporting Evidence:
PMID:27884763
THCA biotransformation into cholic acid was enhanced in cells overexpressing ACOX2, but not in those overexpressing mutACOX2.
GO:0005777 peroxisome
ISS
GO_REF:0000024
ACCEPT
Summary: Peroxisomal localization transferred by sequence similarity from ACOX1 (UniProtKB:P07872). Consistent with the direct experimental peroxisomal localization of ACOX2.
Reason: Redundant with strong direct evidence (IDA/IMP) for peroxisomal localization. The SKL PTS1 signal and experimental data confirm the peroxisome location.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
SUBCELLULAR LOCATION: Peroxisome
GO:0033540 fatty acid beta-oxidation using acyl-CoA oxidase
IMP
PMID:27884763
ACOX2 deficiency: An inborn error of bile acid synthesis ide...
ACCEPT
Summary: Involvement in acyl-CoA-oxidase-mediated beta-oxidation supported by mutational phenotype: the R225W mutation reduces ACOX2 function, and patients accumulate C27 bile-acid intermediates with loss of C24 bile acids. Core biological process.
Reason: IMP evidence (loss-of-function R225W phenotype) in PMID:27884763 confirms ACOX2's requirement for the peroxisomal acyl-CoA-oxidase beta-oxidation of C27 intermediates.
Supporting Evidence:
PMID:27884763
The patient's serum and urine showed negligible amounts of C24 bile acids, but augmented levels of C27 intermediates
GO:0033791 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity
ISS
GO_REF:0000024
ACCEPT
Summary: THCA-CoA oxidase activity transferred by sequence similarity from the rat ortholog (UniProtKB:O02767, THCC oxidase). Consistent with the direct experimental activity for human ACOX2.
Reason: Redundant with the IDA/IBA annotations for the same activity. ACOX2 is the human homolog of rat trihydroxycoprostanoyl-CoA oxidase, and the ISS transfer from the rat ortholog is well-founded.
Supporting Evidence:
PMID:8943006
the hBRCACox is the human homolog of rat trihydroxycoprostanoyl-CoA oxidase (rTHCCox)
GO:0042803 protein homodimerization activity
ISS
GO_REF:0000024
ACCEPT
Summary: Homodimerization activity transferred by sequence similarity from ACOX1 (UniProtKB:P07872). UniProt annotates ACOX2 as a homodimer (by similarity).
Reason: Supported by the UniProt SUBUNIT annotation (Homodimer, by similarity). Acyl-CoA oxidase family members characteristically form homodimers. Retained as a by-similarity structural/quaternary annotation.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
SUBUNIT: Homodimer.
GO:0050660 flavin adenine dinucleotide binding
ISS
GO_REF:0000024
ACCEPT
Summary: FAD binding transferred by sequence similarity from ACOX1 (UniProtKB:P07872). ACOX2 is a FAD flavoprotein. Redundant with the IBA/IEA FAD-binding annotations.
Reason: Supported by the UniProt COFACTOR (FAD) annotation and the flavoprotein nature of the acyl-CoA oxidase family. FAD is the essential redox cofactor.
Supporting Evidence:
file:human/ACOX2/ACOX2-uniprot.txt
Name=FAD; Xref=ChEBI:CHEBI:57692
GO:0005782 peroxisomal matrix
TAS
Reactome:R-HSA-192335
ACCEPT
Summary: Peroxisomal matrix localization from Reactome, tied to the curated reaction in which ACOX2 dehydrogenates 25(S) THCA-CoA in the peroxisomal matrix. Accurate compartment for this soluble matrix enzyme.
Reason: Reactome explicitly places the ACOX2-catalyzed THCA-CoA dehydrogenation in the peroxisomal matrix. This is the accurate, specific compartment for the soluble PTS1-targeted enzyme.
Supporting Evidence:
Reactome:R-HSA-192335
This dehydrogenation reaction occurs in the peroxisomal matrix.
GO:0005782 peroxisomal matrix
TAS
Reactome:R-HSA-193369
ACCEPT
Summary: Peroxisomal matrix localization from Reactome, tied to the curated reaction in which ACOX2 dehydrogenates 25(S) DHCA-CoA. Accurate compartment for this soluble matrix enzyme.
Reason: Reactome places the ACOX2-catalyzed DHCA-CoA dehydrogenation in the peroxisomal matrix, consistent with the enzyme's soluble matrix localization. Accurate, specific compartment.
Supporting Evidence:
Reactome:R-HSA-193369
25(S) DHCA-CoA is dehydrogenated to 25(S) 3alpha,7alpha-dihydroxy-5beta-cholest-24-enoyl-CoA
GO:0005782 peroxisomal matrix
TAS
Reactome:R-HSA-389889
ACCEPT
Summary: Peroxisomal matrix localization from Reactome, tied to the curated reaction in which ACOX2:FAD oxidizes (2S)-pristanoyl-CoA. Accurate compartment for this soluble matrix enzyme.
Reason: Reactome places the ACOX2-catalyzed pristanoyl-CoA oxidation in the peroxisomal matrix, consistent with the enzyme's soluble matrix localization. Accurate, specific compartment.
Supporting Evidence:
Reactome:R-HSA-389889
monomeric peroxisomal ACOX2 (bound to FAD cofactor) catalyzes the reaction of (2S)-pristanoyl-CoA
GO:0005782 peroxisomal matrix
TAS
Reactome:R-HSA-9033235
ACCEPT
Summary: Peroxisomal matrix localization from Reactome, from the peroxisomal-import reaction in which PEX5 cargo (including ACOX2) is translocated into the matrix. Accurate destination compartment.
Reason: The reaction describes cargo translocation into the peroxisomal matrix, which is ACOX2's functional destination. Consistent with the other matrix annotations and experimental data.
Supporting Evidence:
Reactome:R-HSA-9033235
Cargo of PEX5S,L translocates from the cytosol to the peroxisomal matrix
GO:0005777 peroxisome
IDA
PMID:8943006
Molecular characterization of the human peroxisomal branched...
ACCEPT
Summary: Direct experimental peroxisomal localization: the human branched-chain acyl-CoA oxidase carries a C-terminal SKL PTS1 signal and was shown to be peroxisomal (and absent from Zellweger livers by immunoblot/immunocytochemistry). Core localization.
Reason: PMID:8943006 provides direct evidence for peroxisomal localization (SKL PTS1; absence in Zellweger patients, a peroxisome biogenesis disorder). Strong support for the peroxisome location.
Supporting Evidence:
PMID:8943006
The C-terminal tripeptide of the protein is SKL, a known peroxisome targeting signal.
GO:0005777 peroxisome
IDA
PMID:2079609
Separate peroxisomal oxidases for fatty acyl-CoAs and trihyd...
ACCEPT
Summary: Peroxisomal localization inferred from human liver enzymology establishing a separate peroxisomal trihydroxycoprostanoyl-CoA oxidase (ACOX2), distinct from palmitoyl-CoA oxidase, catalyzing the first step of peroxisomal beta-oxidation.
Reason: PMID:2079609 demonstrates a distinct peroxisomal trihydroxycoprostanoyl-CoA oxidase in human liver (i.e. ACOX2), supporting its peroxisomal localization. Consistent with all other localization evidence.
Supporting Evidence:
PMID:2079609
Fatty acyl-CoAs as well as the CoA esters of the bile acid intermediates di- and trihydroxycoprostanic acids are beta-oxidized in peroxisomes.

Core Functions

Peroxisomal branched-chain acyl-CoA oxidase (EC 1.3.3.6): FAD-dependent oxidase that catalyzes the first, O2-dependent dehydrogenation step of peroxisomal beta-oxidation, introducing a trans-2,3 double bond into the acyl-CoA and producing H2O2.

Molecular Function:
acyl-CoA oxidase activity
Directly Involved In:
Cellular Locations:
Supporting Evidence:
  • file:human/ACOX2/ACOX2-uniprot.txt
    Reaction=a 2,3-saturated acyl-CoA + O2 = a (2E)-enoyl-CoA + H2O2;

Initiates side-chain shortening of C27 bile-acid intermediates by oxidizing (25S)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA (THCA-CoA) and DHCA-CoA, contributing to peroxisomal synthesis of the mature C24 bile acids; loss of this activity causes ACOX2 deficiency (CBAS6) with C27 intermediate accumulation.

Supporting Evidence:
  • PMID:27884763
    Acyl-CoA oxidase (ACOX2) is involved in the shortening of C27 cholesterol derivatives to generate C24 bile acids.

Oxidizes 2-methyl-branched-chain fatty acyl-CoA esters such as (2S)-pristanoyl-CoA (stereospecific for (2S)-methyl isomers), functioning in peroxisomal beta-oxidation of branched-chain fatty acids with redundancy to ACOX3.

Directly Involved In:
Cellular Locations:
Supporting Evidence:
  • file:human/ACOX2/ACOX2-uniprot.txt
    Reaction=(2S)-pristanoyl-CoA + O2 = (2E)-pristenoyl-CoA + H2O2;

References

Gene Ontology annotation through association of InterPro records with GO terms
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Automatic Gene Ontology annotation based on Rhea mapping
Electronic Gene Ontology annotations created by ARBA machine learning models
Combined Automated Annotation using Multiple IEA Methods
Separate peroxisomal oxidases for fatty acyl-CoAs and trihydroxycoprostanoyl-CoA in human liver.
ACOX2 deficiency: An inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia.
Architecture of the human interactome defines protein communities and disease networks.
A reference map of the human binary protein interactome.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
Molecular characterization of the human peroxisomal branched-chain acyl-CoA oxidase: cDNA cloning, chromosomal assignment, tissue distribution, and evidence for the absence of the protein in Zellweger syndrome.
file:human/ACOX2/ACOX2-uniprot.txt
UniProtKB entry Q99424 (ACOX2_HUMAN), Peroxisomal acyl-coenzyme A oxidase 2
Reactome:R-HSA-192335
25(S) THCA-CoA is dehydrogenated to 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA (THCA-CoA)
Reactome:R-HSA-193369
25(S) DHCA-CoA is dehydrogenated to 25(S) 3alpha,7alpha-dihydroxy-5beta-cholest-24-enoyl-CoA
Reactome:R-HSA-389889
ACOX2:FAD, ACOXL:FAD oxidise (2S)-pristanoyl-CoA to trans-2,3-dehydropristanoyl-CoA
Reactome:R-HSA-9033235
Cargo of PEX5S,L translocates from the cytosol to the peroxisomal matrix
Reactome:R-HSA-9033236
PEX5S,L:Cargo binds PEX13:PEX14:PEX2:PEX10:PEX12 (Docking and Translocation Module)

Suggested Questions for Experts

Q: What is the relative in vivo contribution of ACOX2 vs ACOX3 to pristanoyl-CoA / branched-chain fatty acid beta-oxidation in human tissues, given the reported redundancy?

Q: Do the STRN3 and DYNLT1 interactions reported in high-throughput screens have any physiological relevance to ACOX2 peroxisomal function or regulation?

Suggested Experiments

Experiment: Quantitative enzyme kinetics of purified human ACOX2 on THCA-CoA, DHCA-CoA, (2S)-pristanoyl-CoA, and straight-chain acyl-CoAs (C10, C16) to define physiological substrate preference and confirm the low-efficiency straight-chain activity.

Experiment: Tissue-specific metabolic profiling (bile-acid intermediates, branched-chain fatty acids) in ACOX2-knockout vs ACOX3-knockout models to disentangle the overlapping branched-chain fatty acid roles.

📚 Additional Documentation

Notes

(ACOX2-notes.md)

ACOX2 (human) — gene review notes

UniProtKB: Q99424; HGNC:120; gene ACOX2 (chromosome 3p14.3). 681 aa; C-terminal SKL
peroxisomal targeting signal (PTS1). EC 1.3.3.6. FAD flavoprotein. Homodimer (by similarity).

Deep research note: falcon deep-research provider is out of credits (HTTP 402), so no
-deep-research-falcon.md was generated. This review is grounded in the UniProt record,
the seeded GOA, and cached publications only.

Function

ACOX2 is the human peroxisomal branched-chain acyl-CoA oxidase (originally "hBRCACox";
homolog of rat trihydroxycoprostanoyl-CoA / THCC oxidase). It is a FAD-dependent oxidase
that catalyses the first, oxygen-dependent, rate-limiting dehydrogenation step of
peroxisomal beta-oxidation, removing two hydrogens and introducing a trans-2,3 double bond
into the acyl-CoA, producing H2O2 as a byproduct (UniProt FUNCTION; EC 1.3.3.6).

Two physiological substrate classes:
1. C27 bile-acid intermediates — (25S)-THCA-CoA and DHCA-CoA. ACOX2 initiates the
side-chain shortening that converts C27 cholestanoic acids to the mature C24 bile acids
(cholic / chenodeoxycholic). PMID:27884763
2. 2-methyl-branched-chain fatty acyl-CoAs — e.g. (2S)-pristanoyl-CoA; stereospecific
for (2S)-methyl isomers. Redundant with ACOX3 for pristanoyl-CoA (PMID:29287774, per
UniProt). Also mono-methyl branched-chain FAs (mmBCFA) in brown adipose tissue (by
similarity to mouse Q9QXD1). Low-efficiency straight-chain activity (C10, C16).

The 1990 human-liver enzymology paper PMID:2079609 established that human liver contains a
separate trihydroxycoprostanoyl-CoA oxidase distinct from palmitoyl-CoA oxidase (ACOX1),
explaining why bile-acid metabolism is normal in ACOX1 deficiency — this separate THCC
oxidase is ACOX2.

Localization

Peroxisome / peroxisomal matrix. Direct protein evidence in human liver
PMID:8943006 (immunocytochemistry; SKL PTS1; absent in Zellweger livers) and
PMID:2079609. IMP peroxisomal localization confirmed for both WT and R225W mutant in
HepG2 PMID:27884763. The Reactome TAS cytosol annotations refer to the peroxisomal-import
transit state (PEX5 cargo in cytosol before matrix translocation), not the site of
catalytic activity.

Disease

ACOX2 deficiency / Congenital bile acid synthesis defect 6 (CBAS6; MIM:617308)
autosomal recessive inborn error of bile-acid synthesis. Accumulation of toxic C27
intermediates (THCA, DHCA), negligible C24 bile acids, persistent hypertransaminasemia /
liver fibrosis; variable neurological features (ataxia, cognitive impairment). Known
variants: R225W PMID:27884763 and a large N-terminal deletion (69-682 del) [PMID:27647924,
via UniProt]. Phytanic/pristanic acids remain normal (redundancy with ACOX3 for BCFA).

Molecular function GO landscape

  • GO:0003997 acyl-CoA oxidase activity — parent MF; core (EC 1.3.3.6). Best single MF.
  • GO:0033791 THCA-CoA 24-hydroxylase activity — the bile-acid-specific reaction, IDA in
    PMID:27884763; also directly matches Rhea:46728 in UniProt. Core bile-acid MF.
  • GO:0016402 pristanoyl-CoA oxidase activity — BCFA reaction; UniProt Rhea:40459
    (PubMed:29287774). Valid but redundant with ACOX3.
  • GO:0120523 / GO:0120524 medium-/long-chain fatty acyl-CoA oxidase activity — RHEA IEA
    (decanoyl/hexadecanoyl-CoA). UniProt calls straight-chain activity "low efficiency", so
    these are minor/over-annotations relative to the branched-chain and bile-acid core.
  • GO:0005504 fatty acid binding (IBA) — substrate binding is implied by catalysis but a bare
    "fatty acid binding" MF is uninformative for this enzyme; over-annotation.
  • GO:0050660 FAD binding / GO:0071949 FAD binding — cofactor binding; supported (COFACTOR FAD).
  • GO:0042803 protein homodimerization activity (ISS from P07872/ACOX1) — UniProt SUBUNIT
    "Homodimer (By similarity)"; accept as by-similarity.
  • GO:0005515 protein binding (IPI, STRN3 / DYNLT1) — bare "protein binding" from high-throughput
    interactome screens; uninformative, over-annotated.

Biological process

  • GO:0006699 bile acid biosynthetic process (IDA, PMID:27884763) — core BP.
  • GO:0033540 fatty acid beta-oxidation using acyl-CoA oxidase — the precise BP; IDA/IMP core.
  • GO:0006635 fatty acid beta-oxidation — parent BP; accept.
  • GO:0000038 very long-chain fatty acid metabolic process (IBA) — ACOX2 handles
    branched-chain and C27 bile-acid substrates, not straight VLCFA (that is ACOX1). Likely
    IBA over-propagation; mark over-annotated.
  • GO:0006631 fatty acid metabolic process — broad InterPro IEA; accept as broad-but-correct.

📄 View Raw YAML

id: Q99424
gene_symbol: ACOX2
product_type: PROTEIN
status: INITIALIZED
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  ACOX2 is the human peroxisomal branched-chain acyl-CoA oxidase (EC 1.3.3.6), a
  FAD-dependent flavoenzyme of the acyl-CoA oxidase family. It catalyzes the first,
  oxygen-dependent and rate-limiting dehydrogenation step of peroxisomal beta-oxidation,
  removing two hydrogens and introducing a trans-2,3 double bond into the acyl-CoA
  substrate while generating hydrogen peroxide as a byproduct. Its principal physiological
  substrates are the C27 bile-acid intermediates (25S)-3alpha,7alpha,12alpha-trihydroxy-
  cholestanoyl-CoA (THCA-CoA) and dihydroxycholestanoyl-CoA (DHCA-CoA); ACOX2 initiates the
  side-chain shortening that converts these C27 cholestanoic acids into the mature C24 bile
  acids (cholic and chenodeoxycholic acid). It also oxidizes 2-methyl-branched-chain fatty
  acyl-CoA esters such as (2S)-pristanoyl-CoA (with redundancy to ACOX3) and monomethyl
  branched-chain fatty acids, acting stereospecifically on (2S)-methyl isomers, and can
  oxidize straight-chain acyl-CoAs with low efficiency. ACOX2 is a homodimer that resides in
  the peroxisomal matrix, imported via its C-terminal SKL (PTS1) targeting signal. It is
  expressed in many tissues, most abundantly in liver, kidney and heart. Loss-of-function
  causes ACOX2 deficiency (congenital bile acid synthesis defect 6, CBAS6), an autosomal
  recessive disorder marked by accumulation of toxic C27 bile-acid intermediates, persistent
  hypertransaminasemia and liver fibrosis, with variable neurological features.
existing_annotations:
- term:
    id: GO:0005504
    label: fatty acid binding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      Fatty acid binding propagated by phylogenetic inference. Substrate binding is implicit
      in the acyl-CoA oxidase catalytic mechanism, but a bare "fatty acid binding" molecular
      function term is uninformative for this enzyme, whose informative MF is its acyl-CoA
      oxidase (dehydrogenase) activity. Retained but flagged as an over-annotation.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      ACOX2 acts on acyl-CoA thioesters (branched-chain and C27 bile-acid CoA esters), not
      on free fatty acids, and its informative molecular function is captured by the acyl-CoA
      oxidase activity terms. A generic "fatty acid binding" adds little functional
      information and is more precisely represented by the catalytic MF terms.
    propagation_review:
      root_cause: TERM_SCOPING_PROBLEM
      failure_modes:
      - GRANULARITY_MISMATCH
      - ROLE_CONFLATION
      source_entities:
      - source_id: PANTHER:PTN000097533
        source_status: SUPPORTS_SOURCE_BUT_NOT_TARGET
        comment: >-
          Family-level "fatty acid binding" propagated from the acyl-CoA oxidase clade; ACOX2
          acts on acyl-CoA thioesters, and the informative MF is its acyl-CoA oxidase activity.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: >-
        Involved in peroxisomal beta-oxidation of branched-chain
        fatty acids (BCFAs) and bile acids intermediates.
- term:
    id: GO:0033540
    label: fatty acid beta-oxidation using acyl-CoA oxidase
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Phylogenetically inferred involvement in fatty acid beta-oxidation via an acyl-CoA
      oxidase. This is exactly the pathway ACOX2 participates in, catalyzing the first
      oxidase step of peroxisomal beta-oxidation of branched-chain and bile-acid CoA esters.
    action: ACCEPT
    reason: >-
      Directly supported by experimental data (IDA/IMP from PMID:27884763) and by the UniProt
      PATHWAY assignment to peroxisomal fatty acid beta-oxidation. The IBA is at an
      appropriate level of specificity for an acyl-CoA-oxidase family enzyme.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'Lipid metabolism; peroxisomal fatty acid beta-oxidation.'
- term:
    id: GO:0120524
    label: long-chain fatty acyl-CoA oxidase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      Long-chain acyl-CoA oxidase activity inferred phylogenetically. ACOX2 can oxidize
      straight-chain long-chain acyl-CoAs (e.g. hexadecanoyl-CoA/C16-CoA) but only with low
      efficiency; its physiological substrates are branched-chain and C27 bile-acid CoA
      esters. Retained but noted as a minor/low-efficiency activity rather than a core function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      UniProt explicitly states ACOX2 oxidizes straight-chain acyl-CoAs (C10-CoA, C16-CoA)
      only with low efficiency; long-chain straight-chain oxidation is the physiological role
      of ACOX1, not ACOX2. The term is not wrong (there is measurable C16-CoA activity) but
      over-states its importance relative to the branched-chain/bile-acid core function.
    propagation_review:
      root_cause: TERM_SCOPING_PROBLEM
      failure_modes:
      - FUNCTIONAL_DIVERGENCE
      - GRANULARITY_MISMATCH
      source_entities:
      - source_id: UniProtKB:Q15067
        source_status: SUPPORTS_SOURCE_BUT_NOT_TARGET
        comment: >-
          Long-chain acyl-CoA oxidase activity fits ACOX1-type members; ACOX2 oxidizes
          straight long-chain acyl-CoAs only with low efficiency, its physiological substrates
          being branched-chain and C27 bile-acid CoA esters.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'acyl CoAs such as C10-CoA and C16-CoA with low efficiency'
- term:
    id: GO:0005777
    label: peroxisome
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: >-
      Phylogenetically inferred peroxisomal localization/activity. ACOX2 carries a C-terminal
      SKL (PTS1) signal and is directly demonstrated to be peroxisomal in human liver, and is
      active within the peroxisome.
    action: ACCEPT
    reason: >-
      Consistent with strong experimental evidence (IDA in PMID:8943006 and PMID:2079609; IMP
      in PMID:27884763) and the UniProt SUBCELLULAR LOCATION. is_active_in is appropriate for
      a matrix enzyme acting inside the peroxisome.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'SUBCELLULAR LOCATION: Peroxisome'
- term:
    id: GO:0050660
    label: flavin adenine dinucleotide binding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      FAD binding inferred phylogenetically. ACOX2 is a FAD-dependent flavoprotein oxidase;
      FAD is an essential cofactor for the oxidative dehydrogenation reaction.
    action: ACCEPT
    reason: >-
      Supported by the UniProt COFACTOR annotation (FAD) and by the flavoprotein character of
      the whole acyl-CoA oxidase family. Reactome also describes the ACOX2:FAD holoenzyme.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'Name=FAD; Xref=ChEBI:CHEBI:57692'
- term:
    id: GO:0000038
    label: very long-chain fatty acid metabolic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Involvement in very long-chain fatty acid metabolism inferred phylogenetically. ACOX2's
      physiological substrates are 2-methyl-branched-chain acyl-CoAs and C27 bile-acid
      intermediates, not straight very-long-chain fatty acids, which are the substrates of
      ACOX1. This appears to be over-propagation across the acyl-CoA oxidase clade.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Straight VLCFA beta-oxidation is the role of ACOX1 (palmitoyl-CoA oxidase). Human liver
      enzymology (PMID:2079609) distinguishes the separate trihydroxycoprostanoyl-CoA oxidase
      (ACOX2) from the palmitoyl-CoA oxidase, and UniProt notes only low-efficiency
      straight-chain activity for ACOX2. The VLCFA-metabolism assignment likely reflects
      family-level IBA transfer rather than ACOX2's actual physiological substrate range.
    propagation_review:
      root_cause: PROPAGATION_BAD
      failure_modes:
      - FUNCTIONAL_DIVERGENCE
      source_entities:
      - source_id: UniProtKB:Q15067
        source_status: SUPPORTS_SOURCE_BUT_NOT_TARGET
        comment: >-
          Very-long-chain fatty acid metabolism is the role of ACOX1-type members; human liver
          enzymology (PMID:2079609) separates the trihydroxycoprostanoyl-CoA oxidase (ACOX2)
          from the palmitoyl-CoA oxidase, so this process should not transfer to ACOX2.
    supported_by:
    - reference_id: PMID:2079609
      supporting_text: >-
        The results show that human liver, as rat liver, contains a separate
        trihydroxycoprostanoyl-CoA oxidase.
- term:
    id: GO:0033791
    label: 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase
      activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      THCA-CoA oxidase (24-hydroxylase) activity inferred phylogenetically, with ACOX2 itself
      among the supporting genes (UniProtKB:Q99424 in the WITH/FROM). This is the
      bile-acid-specific reaction ACOX2 catalyzes on the C27 intermediate THCA-CoA.
    action: ACCEPT
    reason: >-
      Directly supported by experimental evidence (IDA in PMID:27884763) and by the UniProt
      catalytic activity for (25S)-THCA-CoA oxidation (Rhea:46728). This is a core molecular
      function.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: >-
        Reaction=(25S)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oyl-
- term:
    id: GO:0003997
    label: acyl-CoA oxidase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Acyl-CoA oxidase activity (EC 1.3.3.6) assigned electronically from InterPro/Rhea. This
      is the defining molecular function of ACOX2 and is experimentally confirmed.
    action: ACCEPT
    reason: >-
      This parent MF term precisely captures ACOX2's biochemistry (a 2,3-saturated acyl-CoA +
      O2 -> a (2E)-enoyl-CoA + H2O2, EC 1.3.3.6), confirmed experimentally in PMID:27884763
      and via the UniProt catalytic activity (Rhea:38959). It is the best single molecular
      function term for this enzyme.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'Reaction=a 2,3-saturated acyl-CoA + O2 = a (2E)-enoyl-CoA + H2O2;'
- term:
    id: GO:0005777
    label: peroxisome
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: located_in
  review:
    summary: >-
      Peroxisomal localization assigned electronically (InterPro / UniProt SubCell). Confirmed
      by direct experimental evidence.
    action: ACCEPT
    reason: >-
      Consistent with the UniProt SUBCELLULAR LOCATION (Peroxisome) and multiple experimental
      annotations (IDA/IMP). The SKL C-terminal PTS1 targets the protein to the peroxisome.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'SUBCELLULAR LOCATION: Peroxisome'
- term:
    id: GO:0005782
    label: peroxisomal matrix
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  qualifier: located_in
  review:
    summary: >-
      Peroxisomal matrix localization assigned by ARBA machine-learning model. As a soluble
      PTS1-targeted matrix enzyme, ACOX2 resides in the peroxisomal matrix, consistent with
      Reactome placing its reactions in the peroxisomal matrix.
    action: ACCEPT
    reason: >-
      ACOX2 is a soluble matrix flavoenzyme (SKL/PTS1 import, not membrane-bound). This is a
      more specific and accurate compartment than the parent "peroxisome" term, and matches
      the Reactome curated location of its catalytic reactions.
    supported_by:
    - reference_id: Reactome:R-HSA-192335
      supporting_text: This dehydrogenation reaction occurs in the peroxisomal matrix.
- term:
    id: GO:0006631
    label: fatty acid metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: involved_in
  review:
    summary: >-
      Broad fatty acid metabolic process assigned from InterPro. Correct but general; ACOX2's
      specific role is captured by fatty acid beta-oxidation and bile acid biosynthetic
      process terms.
    action: ACCEPT
    reason: >-
      A true but broad parent process term. ACOX2 participates in fatty acid metabolism
      (peroxisomal beta-oxidation of branched-chain fatty acids). Kept as an accurate
      high-level annotation; more specific BP terms are also present.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: >-
        Involved in peroxisomal beta-oxidation of branched-chain
        fatty acids (BCFAs) and bile acids intermediates.
- term:
    id: GO:0006635
    label: fatty acid beta-oxidation
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: involved_in
  review:
    summary: >-
      Fatty acid beta-oxidation assigned electronically from InterPro. ACOX2 catalyzes the
      first oxidase step of peroxisomal beta-oxidation, so this is an accurate parent of the
      more specific "fatty acid beta-oxidation using acyl-CoA oxidase" term.
    action: ACCEPT
    reason: >-
      Directly supported by the UniProt PATHWAY (peroxisomal fatty acid beta-oxidation) and
      by experimental data. This is a core biological process for ACOX2.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'Lipid metabolism; peroxisomal fatty acid beta-oxidation.'
- term:
    id: GO:0016402
    label: pristanoyl-CoA oxidase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000116
  qualifier: enables
  review:
    summary: >-
      Pristanoyl-CoA oxidase activity assigned from Rhea (RHEA:40459). ACOX2 oxidizes
      (2S)-pristanoyl-CoA, a 2-methyl-branched-chain fatty acyl-CoA, though it acts
      redundantly with ACOX3 for this substrate.
    action: ACCEPT
    reason: >-
      Supported by the UniProt catalytic activity for (2S)-pristanoyl-CoA (Rhea:40459,
      ECO:0000269|PubMed:29287774). This is a genuine branched-chain fatty acyl-CoA oxidase
      activity of ACOX2.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'Reaction=(2S)-pristanoyl-CoA + O2 = (2E)-pristenoyl-CoA + H2O2;'
- term:
    id: GO:0016491
    label: oxidoreductase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  qualifier: enables
  review:
    summary: >-
      Root-level oxidoreductase activity from ARBA. Correct but very general; ACOX2's
      oxidoreductase function is precisely captured by acyl-CoA oxidase activity.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      This is a high-level grouping term that is technically true (ACOX2 is an oxidoreductase)
      but uninformative given the specific acyl-CoA oxidase activity (EC 1.3.3.6) is already
      annotated. Retained but flagged as too general.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: EC=1.3.3.6
- term:
    id: GO:0016627
    label: oxidoreductase activity, acting on the CH-CH group of donors
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      Oxidoreductase acting on the CH-CH group of donors, from InterPro. This is the correct
      mechanistic class (introduction of a C2-C3 double bond), an intermediate parent of
      acyl-CoA oxidase activity.
    action: ACCEPT
    reason: >-
      Accurate mechanistic parent term: ACOX2 desaturates the alpha-beta (CH-CH) bond of the
      acyl-CoA. It is subsumed by the more specific acyl-CoA oxidase activity but is not
      incorrect. Kept as an accurate intermediate-level annotation.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: >-
        introduces a trans double bond between the alpha and beta
        carbons of the acyl CoA molecules
- term:
    id: GO:0033540
    label: fatty acid beta-oxidation using acyl-CoA oxidase
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  qualifier: involved_in
  review:
    summary: >-
      Fatty acid beta-oxidation using acyl-CoA oxidase, assigned by ARBA. This is the precise
      pathway term for ACOX2 and is also supported experimentally.
    action: ACCEPT
    reason: >-
      Duplicate of the experimentally supported (IDA/IMP, PMID:27884763) and IBA annotations
      for the same term. Precisely describes ACOX2's contribution to peroxisomal
      beta-oxidation.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'Lipid metabolism; peroxisomal fatty acid beta-oxidation.'
- term:
    id: GO:0050660
    label: flavin adenine dinucleotide binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      FAD binding assigned from InterPro. Duplicate of the IBA/ISS FAD-binding annotations;
      ACOX2 is a FAD-dependent flavoprotein.
    action: ACCEPT
    reason: >-
      Supported by the UniProt COFACTOR (FAD) annotation. FAD is the essential redox cofactor
      of this oxidase.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'Name=FAD; Xref=ChEBI:CHEBI:57692'
- term:
    id: GO:0071949
    label: FAD binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      FAD binding (GO:0071949) assigned from InterPro. Semantically equivalent to the
      GO:0050660 FAD-binding annotations; both describe binding of the FAD cofactor.
    action: ACCEPT
    reason: >-
      Supported by the UniProt COFACTOR (FAD) annotation. Retained; this is a valid (if
      redundant with GO:0050660) representation of FAD cofactor binding.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'Name=FAD; Xref=ChEBI:CHEBI:57692'
- term:
    id: GO:0120523
    label: medium-chain fatty acyl-CoA oxidase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000116
  qualifier: enables
  review:
    summary: >-
      Medium-chain acyl-CoA oxidase activity from Rhea (RHEA:40179, decanoyl-CoA). ACOX2 can
      oxidize the medium-chain substrate decanoyl-CoA (C10-CoA), but UniProt characterizes
      straight-chain oxidation as low efficiency.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      There is measurable in vitro activity on decanoyl-CoA (Rhea:40179, PubMed:29287774), so
      the term is not wrong, but UniProt explicitly notes straight-chain acyl-CoA oxidation
      (C10-CoA, C16-CoA) is low efficiency. This is a minor activity, not a core physiological
      function, which is branched-chain and bile-acid CoA-ester oxidation.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'acyl CoAs such as C10-CoA and C16-CoA with low efficiency'
- term:
    id: GO:0120524
    label: long-chain fatty acyl-CoA oxidase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000116
  qualifier: enables
  review:
    summary: >-
      Long-chain acyl-CoA oxidase activity from Rhea (RHEA:40167, hexadecanoyl-CoA). Duplicate
      of the IBA long-chain annotation; represents low-efficiency straight-chain activity.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      In vitro C16-CoA (hexadecanoyl-CoA) oxidation exists (Rhea:40167), but UniProt states it
      is low efficiency; straight-chain long-chain oxidation is the physiological role of
      ACOX1. Flagged as over-annotation relative to ACOX2's branched-chain/bile-acid core.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'acyl CoAs such as C10-CoA and C16-CoA with low efficiency'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:28514442
  qualifier: enables
  review:
    summary: >-
      Bare "protein binding" from a high-throughput affinity-capture interactome screen
      (BioPlex; ACOX2 with STRN3, UniProtKB:Q13033). Uninformative molecular function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Per curation guidelines, bare "protein binding" (GO:0005515) is uninformative. This
      interaction derives from a genome-scale interactome mapping study, not a functional
      characterization; there is no evidence it reflects a physiologically meaningful complex
      of ACOX2. Retained (not removed, per policy for experimental IPIs) but marked as
      over-annotated.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'Q99424; Q13033: STRN3'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32296183
  qualifier: enables
  review:
    summary: >-
      Bare "protein binding" from the HuRI binary interactome map (ACOX2 with DYNLT1,
      UniProtKB:P63172). Uninformative molecular function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Bare "protein binding" from a systematic binary (Y2H) interactome screen is
      uninformative and does not point to a specific biochemical function of ACOX2. Retained
      per policy for experimental IPIs but flagged as over-annotated.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'Q99424; P63172: DYNLT1'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  qualifier: enables
  review:
    summary: >-
      Bare "protein binding" from a proteome-scale interactome network study (BioPlex 3.0;
      ACOX2 with STRN3, UniProtKB:Q13033). Uninformative molecular function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Bare "protein binding" from a high-throughput interactome dataset is uninformative for
      curation and does not establish a functionally relevant ACOX2 complex. Retained per
      policy for experimental IPIs but flagged as over-annotated.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'Q99424; Q13033: STRN3'
- term:
    id: GO:0006699
    label: bile acid biosynthetic process
  evidence_type: IDA
  original_reference_id: PMID:27884763
  qualifier: involved_in
  review:
    summary: >-
      Direct experimental evidence that ACOX2 is involved in bile acid biosynthesis: patients
      with the R225W mutation accumulate C27 intermediates and lack C24 bile acids, and
      overexpression of wild-type (but not mutant) ACOX2 enhances biotransformation of THCA
      into cholic acid. This is a core biological process.
    action: ACCEPT
    reason: >-
      Strong IDA evidence from PMID:27884763 places ACOX2 in the peroxisomal side-chain
      shortening of C27 cholestanoic acids to C24 bile acids. This is one of ACOX2's two core
      physiological roles.
    supported_by:
    - reference_id: PMID:27884763
      supporting_text: >-
        Acyl-CoA oxidase (ACOX2) is involved in the shortening of C27
        cholesterol derivatives to generate C24 bile acids.
    - reference_id: PMID:27884763
      supporting_text: >-
        THCA biotransformation into cholic acid was enhanced in cells overexpressing
        ACOX2, but not in those overexpressing mutACOX2.
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9033235
  qualifier: located_in
  review:
    summary: >-
      Cytosol localization from a Reactome peroxisomal-import reaction (PEX5 cargo
      translocating from cytosol to the peroxisomal matrix). This reflects the transient
      cytosolic import intermediate of matrix proteins, not the compartment where ACOX2 is
      catalytically active.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      ACOX2 is a PTS1 (SKL) matrix enzyme; peroxisomal matrix proteins are synthesized in the
      cytosol and imported post-translationally, so a transient cytosolic pool exists, but the
      functional/steady-state location is the peroxisomal matrix. The cytosol annotation
      captures the import-pathway transit state rather than the site of ACOX2 activity.
    supported_by:
    - reference_id: Reactome:R-HSA-9033235
      supporting_text: Cargo of PEX5S,L translocates from the cytosol to the peroxisomal matrix
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9033236
  qualifier: located_in
  review:
    summary: >-
      Cytosol localization from a Reactome peroxisomal-import docking reaction (PEX5:cargo
      binding the PEX13/PEX14 docking-translocation module). Like the sibling annotation, this
      reflects the cytosolic import intermediate, not ACOX2's catalytic compartment.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Same rationale as the other cytosol annotation: this is the transient cytosolic
      import/docking state of the PTS1-targeted matrix enzyme, not its functional location,
      which is the peroxisomal matrix.
    supported_by:
    - reference_id: Reactome:R-HSA-9033236
      supporting_text: >-
        PEX5S,L:Cargo binds PEX13:PEX14:PEX2:PEX10:PEX12 (Docking and Translocation
- term:
    id: GO:0005777
    label: peroxisome
  evidence_type: IMP
  original_reference_id: PMID:27884763
  qualifier: located_in
  review:
    summary: >-
      Peroxisomal localization confirmed by immunofluorescence in HepG2 cells overexpressing
      wild-type and R225W-mutant ACOX2; both showed peroxisomal localization. Direct
      experimental support for the peroxisome location.
    action: ACCEPT
    reason: >-
      PMID:27884763 experimentally demonstrates peroxisomal localization of ACOX2 (both WT and
      mutant). Consistent with the UniProt SUBCELLULAR LOCATION and the IDA localizations.
    supported_by:
    - reference_id: PMID:27884763
      supporting_text: >-
        Immunofluorescence studies showed similar
        protein size and peroxisomal localization for both normal and mutated variants.
- term:
    id: GO:0033540
    label: fatty acid beta-oxidation using acyl-CoA oxidase
  evidence_type: IDA
  original_reference_id: PMID:27884763
  qualifier: involved_in
  review:
    summary: >-
      Direct experimental evidence for ACOX2's role in acyl-CoA-oxidase-mediated
      beta-oxidation, shown via its bile-acid intermediate (THCA) processing that requires
      functional ACOX2. Core biological process.
    action: ACCEPT
    reason: >-
      PMID:27884763 demonstrates that functional ACOX2 is required for the oxidase step that
      processes C27 bile-acid CoA intermediates during peroxisomal beta-oxidation. Precise
      pathway term.
    supported_by:
    - reference_id: PMID:27884763
      supporting_text: >-
        THCA biotransformation into cholic acid was enhanced in cells overexpressing
        ACOX2, but not in those overexpressing mutACOX2.
- term:
    id: GO:0033791
    label: 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase
      activity
  evidence_type: IDA
  original_reference_id: PMID:27884763
  qualifier: enables
  review:
    summary: >-
      Direct experimental evidence for THCA-CoA oxidase activity: wild-type ACOX2, but not the
      R225W mutant, enhances biotransformation of THCA to cholic acid, establishing this
      specific catalytic activity on the C27 bile-acid intermediate. Core molecular function.
    action: ACCEPT
    reason: >-
      IDA evidence in PMID:27884763 directly supports ACOX2's activity on the C27
      trihydroxycholestanoyl-CoA substrate. Corresponds to the UniProt catalytic activity
      (Rhea:46728) for (25S)-THCA-CoA oxidation. This is a core molecular function.
    supported_by:
    - reference_id: PMID:27884763
      supporting_text: >-
        THCA biotransformation into cholic acid was enhanced in cells overexpressing
        ACOX2, but not in those overexpressing mutACOX2.
- term:
    id: GO:0005777
    label: peroxisome
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: located_in
  review:
    summary: >-
      Peroxisomal localization transferred by sequence similarity from ACOX1 (UniProtKB:P07872).
      Consistent with the direct experimental peroxisomal localization of ACOX2.
    action: ACCEPT
    reason: >-
      Redundant with strong direct evidence (IDA/IMP) for peroxisomal localization. The SKL
      PTS1 signal and experimental data confirm the peroxisome location.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'SUBCELLULAR LOCATION: Peroxisome'
- term:
    id: GO:0033540
    label: fatty acid beta-oxidation using acyl-CoA oxidase
  evidence_type: IMP
  original_reference_id: PMID:27884763
  qualifier: involved_in
  review:
    summary: >-
      Involvement in acyl-CoA-oxidase-mediated beta-oxidation supported by mutational
      phenotype: the R225W mutation reduces ACOX2 function, and patients accumulate C27
      bile-acid intermediates with loss of C24 bile acids. Core biological process.
    action: ACCEPT
    reason: >-
      IMP evidence (loss-of-function R225W phenotype) in PMID:27884763 confirms ACOX2's
      requirement for the peroxisomal acyl-CoA-oxidase beta-oxidation of C27 intermediates.
    supported_by:
    - reference_id: PMID:27884763
      supporting_text: >-
        The patient's serum and urine showed negligible amounts of C24 bile
        acids, but augmented levels of C27 intermediates
- term:
    id: GO:0033791
    label: 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase
      activity
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: enables
  review:
    summary: >-
      THCA-CoA oxidase activity transferred by sequence similarity from the rat ortholog
      (UniProtKB:O02767, THCC oxidase). Consistent with the direct experimental activity for
      human ACOX2.
    action: ACCEPT
    reason: >-
      Redundant with the IDA/IBA annotations for the same activity. ACOX2 is the human homolog
      of rat trihydroxycoprostanoyl-CoA oxidase, and the ISS transfer from the rat ortholog is
      well-founded.
    supported_by:
    - reference_id: PMID:8943006
      supporting_text: >-
        the hBRCACox is the human homolog of rat trihydroxycoprostanoyl-CoA
        oxidase (rTHCCox)
- term:
    id: GO:0042803
    label: protein homodimerization activity
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: enables
  review:
    summary: >-
      Homodimerization activity transferred by sequence similarity from ACOX1 (UniProtKB:P07872).
      UniProt annotates ACOX2 as a homodimer (by similarity).
    action: ACCEPT
    reason: >-
      Supported by the UniProt SUBUNIT annotation (Homodimer, by similarity). Acyl-CoA oxidase
      family members characteristically form homodimers. Retained as a by-similarity
      structural/quaternary annotation.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'SUBUNIT: Homodimer.'
- term:
    id: GO:0050660
    label: flavin adenine dinucleotide binding
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: enables
  review:
    summary: >-
      FAD binding transferred by sequence similarity from ACOX1 (UniProtKB:P07872). ACOX2 is a
      FAD flavoprotein. Redundant with the IBA/IEA FAD-binding annotations.
    action: ACCEPT
    reason: >-
      Supported by the UniProt COFACTOR (FAD) annotation and the flavoprotein nature of the
      acyl-CoA oxidase family. FAD is the essential redox cofactor.
    supported_by:
    - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
      supporting_text: 'Name=FAD; Xref=ChEBI:CHEBI:57692'
- term:
    id: GO:0005782
    label: peroxisomal matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-192335
  qualifier: located_in
  review:
    summary: >-
      Peroxisomal matrix localization from Reactome, tied to the curated reaction in which
      ACOX2 dehydrogenates 25(S) THCA-CoA in the peroxisomal matrix. Accurate compartment for
      this soluble matrix enzyme.
    action: ACCEPT
    reason: >-
      Reactome explicitly places the ACOX2-catalyzed THCA-CoA dehydrogenation in the
      peroxisomal matrix. This is the accurate, specific compartment for the soluble
      PTS1-targeted enzyme.
    supported_by:
    - reference_id: Reactome:R-HSA-192335
      supporting_text: This dehydrogenation reaction occurs in the peroxisomal matrix.
- term:
    id: GO:0005782
    label: peroxisomal matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-193369
  qualifier: located_in
  review:
    summary: >-
      Peroxisomal matrix localization from Reactome, tied to the curated reaction in which
      ACOX2 dehydrogenates 25(S) DHCA-CoA. Accurate compartment for this soluble matrix enzyme.
    action: ACCEPT
    reason: >-
      Reactome places the ACOX2-catalyzed DHCA-CoA dehydrogenation in the peroxisomal matrix,
      consistent with the enzyme's soluble matrix localization. Accurate, specific compartment.
    supported_by:
    - reference_id: Reactome:R-HSA-193369
      supporting_text: 25(S) DHCA-CoA is dehydrogenated to 25(S) 3alpha,7alpha-dihydroxy-5beta-cholest-24-enoyl-CoA
- term:
    id: GO:0005782
    label: peroxisomal matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-389889
  qualifier: located_in
  review:
    summary: >-
      Peroxisomal matrix localization from Reactome, tied to the curated reaction in which
      ACOX2:FAD oxidizes (2S)-pristanoyl-CoA. Accurate compartment for this soluble matrix
      enzyme.
    action: ACCEPT
    reason: >-
      Reactome places the ACOX2-catalyzed pristanoyl-CoA oxidation in the peroxisomal matrix,
      consistent with the enzyme's soluble matrix localization. Accurate, specific compartment.
    supported_by:
    - reference_id: Reactome:R-HSA-389889
      supporting_text: >-
        monomeric peroxisomal ACOX2 (bound to FAD
        cofactor) catalyzes the reaction of (2S)-pristanoyl-CoA
- term:
    id: GO:0005782
    label: peroxisomal matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9033235
  qualifier: located_in
  review:
    summary: >-
      Peroxisomal matrix localization from Reactome, from the peroxisomal-import reaction in
      which PEX5 cargo (including ACOX2) is translocated into the matrix. Accurate destination
      compartment.
    action: ACCEPT
    reason: >-
      The reaction describes cargo translocation into the peroxisomal matrix, which is ACOX2's
      functional destination. Consistent with the other matrix annotations and experimental
      data.
    supported_by:
    - reference_id: Reactome:R-HSA-9033235
      supporting_text: Cargo of PEX5S,L translocates from the cytosol to the peroxisomal matrix
- term:
    id: GO:0005777
    label: peroxisome
  evidence_type: IDA
  original_reference_id: PMID:8943006
  qualifier: located_in
  review:
    summary: >-
      Direct experimental peroxisomal localization: the human branched-chain acyl-CoA oxidase
      carries a C-terminal SKL PTS1 signal and was shown to be peroxisomal (and absent from
      Zellweger livers by immunoblot/immunocytochemistry). Core localization.
    action: ACCEPT
    reason: >-
      PMID:8943006 provides direct evidence for peroxisomal localization (SKL PTS1; absence in
      Zellweger patients, a peroxisome biogenesis disorder). Strong support for the peroxisome
      location.
    supported_by:
    - reference_id: PMID:8943006
      supporting_text: >-
        The C-terminal tripeptide of the protein is SKL, a
        known peroxisome targeting signal.
- term:
    id: GO:0005777
    label: peroxisome
  evidence_type: IDA
  original_reference_id: PMID:2079609
  qualifier: located_in
  review:
    summary: >-
      Peroxisomal localization inferred from human liver enzymology establishing a separate
      peroxisomal trihydroxycoprostanoyl-CoA oxidase (ACOX2), distinct from palmitoyl-CoA
      oxidase, catalyzing the first step of peroxisomal beta-oxidation.
    action: ACCEPT
    reason: >-
      PMID:2079609 demonstrates a distinct peroxisomal trihydroxycoprostanoyl-CoA oxidase in
      human liver (i.e. ACOX2), supporting its peroxisomal localization. Consistent with all
      other localization evidence.
    supported_by:
    - reference_id: PMID:2079609
      supporting_text: >-
        Fatty acyl-CoAs as well as the CoA esters of the bile acid intermediates di- and
        trihydroxycoprostanic acids are beta-oxidized in peroxisomes.
core_functions:
- description: >-
    Peroxisomal branched-chain acyl-CoA oxidase (EC 1.3.3.6): FAD-dependent oxidase that
    catalyzes the first, O2-dependent dehydrogenation step of peroxisomal beta-oxidation,
    introducing a trans-2,3 double bond into the acyl-CoA and producing H2O2.
  molecular_function:
    id: GO:0003997
    label: acyl-CoA oxidase activity
  directly_involved_in:
  - id: GO:0006635
    label: fatty acid beta-oxidation
  supported_by:
  - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
    supporting_text: 'Reaction=a 2,3-saturated acyl-CoA + O2 = a (2E)-enoyl-CoA + H2O2;'
  locations:
  - id: GO:0005782
    label: peroxisomal matrix
- description: >-
    Initiates side-chain shortening of C27 bile-acid intermediates by oxidizing
    (25S)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA (THCA-CoA) and DHCA-CoA,
    contributing to peroxisomal synthesis of the mature C24 bile acids; loss of this activity
    causes ACOX2 deficiency (CBAS6) with C27 intermediate accumulation.
  molecular_function:
    id: GO:0033791
    label: 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity
  directly_involved_in:
  - id: GO:0006699
    label: bile acid biosynthetic process
  supported_by:
  - reference_id: PMID:27884763
    supporting_text: >-
      Acyl-CoA oxidase (ACOX2) is involved in the shortening of C27
      cholesterol derivatives to generate C24 bile acids.
  locations:
  - id: GO:0005782
    label: peroxisomal matrix
- description: >-
    Oxidizes 2-methyl-branched-chain fatty acyl-CoA esters such as (2S)-pristanoyl-CoA
    (stereospecific for (2S)-methyl isomers), functioning in peroxisomal beta-oxidation of
    branched-chain fatty acids with redundancy to ACOX3.
  molecular_function:
    id: GO:0016402
    label: pristanoyl-CoA oxidase activity
  directly_involved_in:
  - id: GO:0006635
    label: fatty acid beta-oxidation
  supported_by:
  - reference_id: file:human/ACOX2/ACOX2-uniprot.txt
    supporting_text: 'Reaction=(2S)-pristanoyl-CoA + O2 = (2E)-pristenoyl-CoA + H2O2;'
  locations:
  - id: GO:0005782
    label: peroxisomal matrix
proposed_new_terms: []
suggested_questions:
- question: >-
    What is the relative in vivo contribution of ACOX2 vs ACOX3 to pristanoyl-CoA /
    branched-chain fatty acid beta-oxidation in human tissues, given the reported redundancy?
- question: >-
    Do the STRN3 and DYNLT1 interactions reported in high-throughput screens have any
    physiological relevance to ACOX2 peroxisomal function or regulation?
suggested_experiments:
- description: >-
    Quantitative enzyme kinetics of purified human ACOX2 on THCA-CoA, DHCA-CoA,
    (2S)-pristanoyl-CoA, and straight-chain acyl-CoAs (C10, C16) to define physiological
    substrate preference and confirm the low-efficiency straight-chain activity.
- description: >-
    Tissue-specific metabolic profiling (bile-acid intermediates, branched-chain fatty acids)
    in ACOX2-knockout vs ACOX3-knockout models to disentangle the overlapping branched-chain
    fatty acid roles.
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
    by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000116
  title: Automatic Gene Ontology annotation based on Rhea mapping
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:2079609
  title: Separate peroxisomal oxidases for fatty acyl-CoAs and trihydroxycoprostanoyl-CoA
    in human liver.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Establishes a distinct peroxisomal trihydroxycoprostanoyl-CoA oxidase in human liver
      (i.e. ACOX2), separate from palmitoyl-CoA oxidase; supports peroxisomal localization and
      the bile-acid-intermediate role. Cited quotes verified verbatim against the cached
      abstract.
- id: PMID:27884763
  title: 'ACOX2 deficiency: An inborn error of bile acid synthesis identified in an
    adolescent with persistent hypertransaminasemia.'
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Primary experimental (IDA/IMP) source: patient R225W mutation causes accumulation of C27
      intermediates and loss of C24 bile acids; WT (not mutant) ACOX2 enhances THCA to cholic
      acid conversion; peroxisomal localization confirmed by immunofluorescence. Directly
      supports the bile-acid biosynthesis and THCA-CoA oxidase core functions.
- id: PMID:28514442
  title: Architecture of the human interactome defines protein communities and disease
    networks.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      High-throughput (BioPlex) interactome study yielding a bare "protein binding"
      (ACOX2-STRN3) annotation. Correctly cited but functionally uninformative for ACOX2;
      marked as over-annotation.
- id: PMID:32296183
  title: A reference map of the human binary protein interactome.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      HuRI binary (Y2H) interactome map yielding a bare "protein binding" (ACOX2-DYNLT1)
      annotation. Correctly cited but functionally uninformative for ACOX2; marked as
      over-annotation.
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human
    interactome.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Proteome-scale (BioPlex 3.0) interactome study yielding a bare "protein binding"
      (ACOX2-STRN3) annotation. Correctly cited but functionally uninformative for ACOX2;
      marked as over-annotation.
- id: PMID:8943006
  title: 'Molecular characterization of the human peroxisomal branched-chain acyl-CoA
    oxidase: cDNA cloning, chromosomal assignment, tissue distribution, and evidence
    for the absence of the protein in Zellweger syndrome.'
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Original molecular characterization of human ACOX2 (hBRCACox): 681-aa protein, C-terminal
      SKL PTS1, peroxisomal (absent in Zellweger livers), human homolog of rat THCC oxidase.
      Supports peroxisomal localization and identity. Quotes verified verbatim.
- id: file:human/ACOX2/ACOX2-uniprot.txt
  title: UniProtKB entry Q99424 (ACOX2_HUMAN), Peroxisomal acyl-coenzyme A oxidase 2
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Curated UniProt record. Source of FUNCTION, catalytic activities (EC 1.3.3.6; Rhea
      reactions for THCA-CoA, pristanoyl-CoA, decanoyl/hexadecanoyl-CoA), FAD cofactor,
      homodimer subunit, peroxisome subcellular location, and CBAS6 disease association.
- id: Reactome:R-HSA-192335
  title: 25(S) THCA-CoA is dehydrogenated to 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA
    (THCA-CoA)
  findings: []
- id: Reactome:R-HSA-193369
  title: 25(S) DHCA-CoA is dehydrogenated to 25(S) 3alpha,7alpha-dihydroxy-5beta-cholest-24-enoyl-CoA
  findings: []
- id: Reactome:R-HSA-389889
  title: ACOX2:FAD, ACOXL:FAD oxidise (2S)-pristanoyl-CoA to trans-2,3-dehydropristanoyl-CoA
  findings: []
- id: Reactome:R-HSA-9033235
  title: Cargo of PEX5S,L translocates from the cytosol to the peroxisomal matrix
  findings: []
- id: Reactome:R-HSA-9033236
  title: PEX5S,L:Cargo binds PEX13:PEX14:PEX2:PEX10:PEX12 (Docking and Translocation
    Module)
  findings: []